시장보고서
상품코드
1575044

인간 간 모델 시장 : 제품 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Human Liver Model Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 303 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

인간 간 모델 시장 규모는 2023년 12억 132만 달러로 2024년부터 2032년까지 10.99%의 CAGR로 확대될 것으로 예상됩니다.

인간 간 모델 시장 - 시장 역학

신약 개발 시장 개척, 3D 세포배양 기술, 간질환의 확산으로 시장 수요 촉진 전망

간은 약물 대사의 주요 부위이기 때문에 간 모델은 약물 대사, 독성 및 효능을 테스트하기 위한 신약 개발에 필수적입니다. 제약 업계의 정밀의료 및 생물학적 제제를 포함한 의약품 연구개발에 대한 투자 확대는 인간 간 모델에 대한 수요를 증가시켜 시장 성장을 견인하고 있으며, 3D 세포배양, 미세유체 시스템 및 장기 온칩 플랫폼의 기술 발전으로 보다 생리학적으로 적합한 간 모델을 제작할 수 있게 되었습니다. 이러한 혁신은 간 기능 및 간 반응에 대한 더 나은 시뮬레이션을 제공함으로써 연구자들의 채택을 촉진하고 있습니다.

간염, 비알코올성 지방간 질환(NAFLD), 간경변증, 간암 등 간 질환의 발병률이 증가함에 따라 첨단 연구 도구와 치료 솔루션에 대한 요구가 증가하고 있습니다. 이에 따라 질병 메커니즘을 연구하고 새로운 치료법을 개발하기 위한 정확한 간 모델에 대한 수요가 증가하고 있습니다. 규제 기관과 과학계는 동물 실험을 줄일 수 있는 대체 시험법을 요구하고 있습니다. 간 오가노이드 및 Liver-on-a-chip 시스템과 같은 인간 간 모델은 실행 가능한 체외 대체 방법을 제공하여 시장 성장을 촉진하고 있습니다. 전 세계 정부와 연구기관들은 간 모델을 포함한 장기 모델링 기술을 개선하기 위한 프로젝트에 대한 자금 지원을 늘리고 있습니다. 이러한 자금 지원은 혁신적인 간 모델의 개발과 상용화를 가속화하고 있습니다.

인간 간 모델 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 10.99%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 제약 연구 및 의약품 개발에 대한 높은 적용으로 인해 2D 모델 부문이 2023년 가장 큰 시장 점유율을 차지할 것으로 예측됐습니다.

용도별로는 첨단 간 모델 수요 가속화로 인해 ADME 연구 분야가 2023년 주요 응용 분야로 부상했습니다.

최종사용자 부문별로 보면 2023년 바이오제약 기업 부문은 약물 간 상호작용, 약물 대사 등을 평가하기 위한 간 모델 필요성이 증가함에 따라 주요 최종사용자 부문이 되었습니다.

지역별로는 북미가 2023년 매출을 주도했는데, 이는 규제 환경이 우호적이기 때문으로 분석됩니다.

인간 간 모델 시장 - 세분화 분석:

세계 인간 간 모델 시장은 제품 유형, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 2D 모델과 3D 모델의 두 가지로 나뉘며, 2D 모델이 시장을 독점하고 있습니다. 질병 모델링 및 in vivo 조건에서의 사용 증가는 주로 이 부문의 성장을 주도하고 있습니다.

시장은 용도별로 ADME 테스트, 독성 테스트, 질병 모델링, 기타 등 4가지로 분류되며, ADME 테스트 분야가 시장을 주도하고 있습니다. 독성 테스트 분야는 in-vitro 테스트의 수요 증가로 인해 예측 기간 동안 가장 빠른 CAGR로 확장될 것으로 추정됩니다.

시장은 최종사용자에 따라 CRO, 학술 연구, 바이오 제약 회사, 학술 연구의 세 가지 범주로 나뉩니다. 바이오 제약 회사 부문은 시장을 독점하고 있으며 예측 기간 동안 높은 우위를 유지할 것으로 예상됩니다. 간 모델은 바이오 제약 회사가 의약품 개발 프로세스의 정확성을 신속하게 평가할 수 있도록 돕습니다.

인간 간 모델 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 북미는 주요 제약사 및 생명공학 기업의 존재, 많은 연구 기관, 발달된 의료 인프라로 인해 전 세계 인간 간 모델 시장에서 큰 점유율을 차지하고 있습니다. 아시아태평양은 생명공학에 대한 투자 증가, 제약 산업 확대, 간 질환의 유병률 증가로 인해 인간 간 모델 시장에서 빠른 성장을 보이고 있습니다. 중국, 인도와 같은 국가에 대한 제약 및 임상 연구 아웃소싱 증가, 생물의학 연구에 대한 정부 자금이 증가하고 있습니다.

인간 간 모델 시장 - 경쟁 상황:

인간 간 모델 시장의 경쟁 구도는 기존 기업, 혁신적 스타트업, 연구기관 등 다양한 기업들에 의해 형성되고 있습니다. 이들 기업들은 약물 테스트, 질병 모델링 등의 수요 증가에 대응하기 위해 첨단 간 모델 개발에 집중하고 있습니다. 기업들은 3D 바이오프린트 간 조직, 미세유체 간 온칩(microfluidic liver-on-chip) 장치 등 보다 생리학적으로 적합한 간 모델 개발에 집중하고 있습니다. 주요 기업들은 제약사 및 학술 기관과 협력하여 간 모델을 검증하고 상용화하기 위해 노력하고 있습니다.

2024년 4월, CN Bio Innovations는 Organ-on-a-chip(OOC) 기술을 개발하기 위해 시리즈 B에서 2,100만 달러의 투자를 유치했습니다.

2022년, InSphero AG는 NASH 및 간섬유증 연구를 위한 고급 모델을 발표하여 복잡한 간 질환의 더 나은 in vitro 모델링을 가능하게 했습니다.

목차

제1장 인간 간 모델 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 인간 간 모델의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 인간 간 모델 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 인간 간 모델 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 인간 간 모델 시장 상황

  • 인간 간 모델 시장 점유율 분석, 2023년
  • 내역 데이터 : 주요 제조업체별
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 인간 간 모델 시장 - 제품 유형별

  • 개요
    • 부문 점유율 분석 : 제품 유형별
    • 2D 모델
    • 3D 모델

제8장 인간 간 모델 시장 - 용도별

  • 개요
    • 부문 점유율 분석 : 용도별
    • ADME 연구
    • 독성 시험
    • 질환 모델화
    • 기타

제9장 인간 간 모델 시장 - 최종사용자별

  • 개요
    • 부문 점유율 분석 : 최종사용자별
    • 바이오의약품 기업
    • CRO
    • 학술 연구

제10장 인간 간 모델 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 인간 간 모델 업계

  • 경쟁 대시보드
  • 기업 개요
    • Emulate, Inc.
    • Organovo Holdings, Inc.
    • InSphero AG
    • Cyfuse Biomedical K.K.
    • CN Bio Innovations
    • BioIVT
    • Hurel Corporation
    • HepaRG
    • Kirkstall Ltd.
    • TissUse GmbH
    • MIMETAS B.V.
    • CellSystems Biotechnologie Vertrieb GmbH
    • Promega Corporation
    • Merck KGaA
    • 기타

제12장 애널리스트의 전방위 전망

ksm 24.11.15

REPORT HIGHLIGHT

Human Liver Model Market size was valued at USD 1,201.32 Million in 2023, expanding at a CAGR of 10.99% from 2024 to 2032.

The human liver model is an experimental or computational representation of the human liver used for research and medical purposes. These models are designed to study liver function, disease, and drug interactions in a controlled environment. There are several types of human liver models, each serving distinct purposes.

Human Liver Model Market- Market Dynamics

Growth in drug discovery & development, 3D cell culture technology and prevalence of liver disorders is expected to propel market demand

Liver models are essential in drug discovery for testing drug metabolism, toxicity, and efficacy, as the liver is a primary site of drug metabolism. The pharmaceutical industry's growing investment in drug research and development, including precision medicine and biologics, has increased the demand for human liver models, which in turn is boosting market growth. Technological advancements in 3D cell culture, microfluidic systems, and organ-on-a-chip platforms have enabled the creation of more physiologically relevant liver models. These innovations offer better simulation of liver function and response, encouraging adoption by researchers.

The rising incidence of liver diseases such as hepatitis, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and liver cancer has led to an increased need for advanced research tools and therapeutic solutions. This, in turn, drives the demand for accurate liver models for studying disease mechanisms and developing new treatments. Regulatory bodies and the scientific community are pushing for alternative testing methods to reduce animal testing. Human liver models, including liver organoids and liver-on-a-chip systems, provide a viable in vitro alternative, driving market growth. Governments and research institutions worldwide are increasingly funding projects aimed at improving organ modeling technologies, including liver models. This funding accelerates the development and commercialization of innovative liver models.

Human Liver Model Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.99% over the forecast period (2024-2032)

Based on Product Type segmentation, the 2D models segment was predicted to show maximum market share in the year 2023, owing to its high applications in pharmaceutical research & drug development.

Based on Application segmentation, ADME studies segment was the leading Application segment in 2023, due to the accelerating demand for advanced liver models.

Based on End User segmentation, biopharmaceutical companies' segment was the leading End User segment in 2023, due to the growing need for liver models in assessing drug-drug interactions, drug metabolism, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the supportive regulatory environment.

Human Liver Model Market- Segmentation Analysis:

Global Human Liver Model Market is segmented on the basis of Product Type, Application, End User, and Region.

The market is divided into two categories based on Product Type: 2D models and 3D models. The 2D models segment dominates the market. Increasing application in disease modelling and in vivo conditions is mainly fueling segment growth.

The market is divided into four categories based on Application: ADME studies, toxicology testing, disease modelling and others. The ADME studies segment dominates the market. The toxicology testing segment is estimated to expand at the fastest CAGR over the forecast period with rising demand from in-vitro testing.

The market is divided into three categories based on End User: biopharmaceutical companies. CROs, and academic research. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Liver models help biopharma companies to assess accuracy of their drug development processes in rapid time.

Human Liver Model Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the global human liver model market due to the presence of major pharmaceutical and biotechnology companies, a high number of research institutions, and advanced healthcare infrastructure. The Asia-Pacific region is experiencing rapid growth in the human liver model market, driven by increasing investment in biotechnology, expanding pharmaceutical industries, and rising prevalence of liver diseases. Growing pharmaceutical and clinical research outsourcing to countries like China and India, increasing government funding for biomedical research.

Human Liver Model Market- Competitive Landscape:

The competitive landscape of the human liver model market is shaped by a variety of companies, including established players, innovative startups, and research organizations. These companies are focusing on developing advanced liver models to cater to the growing demand for drug testing, disease modeling, etc. Companies are focusing on developing more physiologically relevant liver models, such as 3D bio printed liver tissues and microfluidic liver-on-chip devices. Key players are collaborating with pharmaceutical companies and academic institutions to validate and commercialize their liver models.

In April 2024, CN Bio Innovations received USD 21 million in Series-B funding to develop its organ-on-a-chip (OOC) technologies.

In 2022, InSphero AG introduced advanced models for NASH and liver fibrosis research, enabling better in vitro modeling of complex liver diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN LIVER MODEL MARKET KEY PLAYERS

  • Emulate, Inc.
  • Organovo Holdings, Inc.
  • InSphero AG
  • Cyfuse Biomedical K.K.
  • CN Bio Innovations
  • BioIVT
  • Hµrel Corporation
  • HepaRG
  • Kirkstall Ltd.
  • TissUse GmbH
  • MIMETAS B.V.
  • Insphero AG
  • CellSystems Biotechnologie Vertrieb GmbH
  • Promega Corporation
  • Merck KGaA
  • Others

GLOBAL HUMAN LIVER MODEL MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • 2D Models
  • 3D Models

GLOBAL HUMAN LIVER MODEL MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • ADME studies
  • Toxicology testing
  • Disease modelling
  • Others

GLOBAL HUMAN LIVER MODEL MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical Companies
  • CROs
  • Academic Research

GLOBAL HUMAN LIVER MODEL MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Liver Model Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Liver Model Market Snippet by Product Type
    • 2.1.2. Human Liver Model Market Snippet by Application
    • 2.1.3. Human Liver Model Market Snippet by End User
    • 2.1.4. Human Liver Model Market Snippet by Country
    • 2.1.5. Human Liver Model Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Liver Model Key Market Trends

  • 3.1. Human Liver Model Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Liver Model Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Liver Model Market Opportunities
  • 3.4. Human Liver Model Market Future Trends

4. Human Liver Model Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Liver Model Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Liver Model Market Landscape

  • 6.1. Human Liver Model Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Liver Model Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. 2D Models
    • 7.1.3. 3D Models

8. Human Liver Model Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. ADME studies
    • 8.1.3. Toxicology testing
    • 8.1.4. Disease modelling
    • 8.1.5. Others

9. Human Liver Model Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical Companies
    • 9.1.3. CROs
    • 9.1.4. Academic Research

10. Human Liver Model Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Human Liver Model Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Human Liver Model Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Human Liver Model Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Human Liver Model Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Human Liver Model Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Human Liver Model Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Emulate, Inc.
    • 11.2.2. Organovo Holdings, Inc.
    • 11.2.3. InSphero AG
    • 11.2.4. Cyfuse Biomedical K.K.
    • 11.2.5. CN Bio Innovations
    • 11.2.6. BioIVT
    • 11.2.7. Hurel Corporation
    • 11.2.8. HepaRG
    • 11.2.9. Kirkstall Ltd.
    • 11.2.10. TissUse GmbH
    • 11.2.11. MIMETAS B.V.
    • 11.2.12. Insphero AG
    • 11.2.13. CellSystems Biotechnologie Vertrieb GmbH
    • 11.2.14. Promega Corporation
    • 11.2.15. Merck KGaA
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제